Sarepta Shares Hit Record High on Hopes for New Drugs
May 04, 2018 at 12:34 PM EDT
The jump could be due to optimism about Sarepta’s gene-therapy program for Duchenne muscular dystrophy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.